CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cardio Diagnostics Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cardio Diagnostics Holdings Inc
311 W. Superior Street, Suite 444
Phone: (302) 281-2147p:302 281-2147 CHICAGO, IL  60645  United States Ticker: CDIOCDIO

Business Summary
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company is engaged in the development and commercialization of artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease. It enables prevention, early detection and assists in the treatment of cardiovascular disease. The Company's Epi+Gen CHD, is a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. Its second product, PrecisionCHD, is an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Its Epi+Gen CHD and PrecisionCHD tests are categorized as laboratory-developed tests (LDTs), which does not require premarket authorization or other Food and Drug Administration (FDA) clearance or approval. It serves a range of patients, clinicians, hospitals/health systems, employers and payors.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board WarrenHosseinion 46 10/1/2022 10/1/2022
Chief Executive Officer, Director Meeshanthini V.Dogan 33
Chief Financial Officer ElisaLuqman 58 3/1/2021 3/1/2021
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Cardio Diagnostics, Inc.
CDIO
MAAQ
MAAQU

General Information
Number of Employees: 7 (As of 3/27/2023)
Outstanding Shares: 21,102,202 (As of 2/2/2024)
Shareholders: 91
Stock Exchange: NASD
Federal Tax Id: 870925574


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024